Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

Diya Surie; Katharine Yuengling; Jennifer DeCuir; Yuwei Zhu; Manjusha Gaglani; Adit Ginde; H. Keipp Talbot; Jonathan Casey; Nicholas Mohr; Shekhar Ghamande; Kevin Gibbs; D. Clark Files; David Hager; Harith Ali; Matthew Prekker; Michelle Gong; Amira Mohamed; Nicholas Johnson; Jay Steingrub; Ithan Peltan; Samuel Brown; Aleda Leis; Akram Khan; Catherine Hough; William Bender; Abhijit Duggal; Jennifer Wilson; Nida Qadir; Steven Chang; Christopher Mallow; Jennie Kwon; Matthew Exline; Adam Lauring; Nathan Shapiro; Cristie Columbus; Ivana Vaughn; Mayur Ramesh; Basmah Safdar; Natasha Halasa; James Chappell; Carlos Grijalva; Adrienne Baughman; Todd Rice; Kelsey Womack; Jin Han; Sydney Swan; Indrani Mukherjee; Nathaniel Lewis; Sascha Ellington; Meredith McMorrow; Emily Martin; Wesley Self; IVY Network

doi:10.15585/mmwr.mm7240a2

Back

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

Journal article

Open access

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

Diya Surie, Katharine Yuengling, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit Ginde, H. Keipp Talbot, Jonathan Casey, Nicholas Mohr, Shekhar Ghamande, …

MMWR. Morbidity and mortality weekly report, Vol.72(40), pp.1083-1088

10/06/2023

DOI: 10.15585/mmwr.mm7240a2

PMCID: PMC10564326

PMID: 37796753

Files and links (1)

url

https://doi.org/10.15585/mmwr.mm7240a2View

Published (Version of record) Open Access

Abstract

What is already known about this topic? In June 2023, CDC recommended the first respiratory syncytial virus (RSV) vaccines for adults aged ≥60 years using shared clinical decision-making. Understanding the severity of RSV disease is needed to guide this clinical decision-making. What is added by this report? During February 2022–May 2023, hospitalizations for RSV were less frequent but were associated with more severe disease than were hospitalizations for COVID-19 or influenza, including receipt of standard flow oxygen therapy, high-flow nasal cannula or noninvasive ventilation, and intensive care unit admission. What are the implications for public health practice? The potential for severe RSV disease among older adults is important to consider as part of shared clinical decision-making when assessing the benefit of RSV vaccination among adults aged ≥60 years.

Adults

Influenza

Intensive Care

Older People

Public Health

Respiratory Diseases

Vaccines

Clinical decision making

COVID-19

COVID-19 vaccines

Decision making

Hispanic Americans

Hospitalization

Hospitals

Illnesses

Infections

Medical laboratories

Oxygen therapy

Patients

Regression analysis

Respiratory syncytial virus

Severe acute respiratory syndrome coronavirus 2

Ventilators

Viral diseases

Viruses

Details

Title: Subtitle: Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023
Creators: Diya Surie
Katharine Yuengling
Jennifer DeCuir
Yuwei Zhu
Manjusha Gaglani
Adit Ginde
H. Keipp Talbot
Jonathan Casey
Nicholas Mohr
Shekhar Ghamande
Kevin Gibbs
D. Clark Files
David Hager
Harith Ali
Matthew Prekker
Michelle Gong
Amira Mohamed
Nicholas Johnson
Jay Steingrub
Ithan Peltan
Samuel Brown
Aleda Leis
Akram Khan
Catherine Hough
William Bender
Abhijit Duggal
Jennifer Wilson
Nida Qadir
Steven Chang
Christopher Mallow
Jennie Kwon
Matthew Exline
Adam Lauring
Nathan Shapiro
Cristie Columbus
Ivana Vaughn
Mayur Ramesh
Basmah Safdar
Natasha Halasa
James Chappell
Carlos Grijalva
Adrienne Baughman
Todd Rice
Kelsey Womack
Jin Han
Sydney Swan
Indrani Mukherjee
Nathaniel Lewis
Sascha Ellington
Meredith McMorrow
Emily Martin
Wesley Self
IVY Network
IVY Network
Resource Type: Journal article
Publication Details: MMWR. Morbidity and mortality weekly report, Vol.72(40), pp.1083-1088
DOI: 10.15585/mmwr.mm7240a2
PMID: 37796753
PMCID: PMC10564326
NLM abbreviation: MMWR Morb Mortal Wkly Rep
ISSN: 0149-2195
eISSN: 1545-861X
Publisher: U.S. Center for Disease Control
Language: English
Date published: 10/06/2023
Academic Unit: Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
Record Identifier: 9984476545402771

Metrics

9 Record Views

73 Times Cited - Web of Science

See more details